Marshall Wace’s Tyra Biosciences TYRA Stock Holding History

Marshall Wace’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.57M	Sell	197,748 -514,143	-72%	-$16.6M	0.01%	1100
2025 Q4	$18.7M	Buy	711,891 +109,876	+18%	+$2.02M	0.02%	653
2025 Q3	$8.42M	Buy	602,015 +173,907	+41%	+$1.98M	0.01%	982
2025 Q2	$4.1M	Buy	428,108 +47,408	+12%	+$450K	﹤0.01%	1240
2025 Q1	$3.54M	Buy	380,700 +326,623	+604%	+$4.23M	﹤0.01%	1210
2024 Q4	$752K	Buy	54,077 +34,463	+176%	+$625K	﹤0.01%	1871
2024 Q3	$461K	Buy	+19,614	New	+$412K	﹤0.01%	1946
2024 Q2	–	Sell	-19,643	Closed	-$322K	–	2980
2024 Q1	$322K	Sell	19,643 -10,358	-35%	-$170K	﹤0.01%	2086
2023 Q4	$416K	Buy	+30,001	New	+$388K	﹤0.01%	1785

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

APMC

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Marshall Wace's TYRA Position: Q1 2026 in Review

Marshall Wace reduced its Tyra Biosciences (TYRA) stake by 72% in Q1 2026, selling an estimated $16.6M and leaving 197,748 shares worth $7.57M. The position accounts for 0.01% of the portfolio, ranked #1100.

Marshall Wace first reported a position in TYRA in Q4 2023 and has held it in 9 quarters since. The position peaked at $18.7M in Q4 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

Marshall Wace held 197,748 shares of Tyra Biosciences worth $7.57M as of Q1 2026.
Marshall Wace sold 514,143 Tyra Biosciences shares in Q1 2026, an estimated $16.6M.
Tyra Biosciences made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1100 holding.
Marshall Wace first reported a position in Tyra Biosciences in Q4 2023 and has held it in 9 quarters since.
Marshall Wace's Tyra Biosciences position peaked at $18.7M in Q4 2025.
164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.